Search

Your search keyword '"Paperini L"' showing total 4 results
Start Over Author "Paperini L" Topic death, sudden, cardiac
4 results on '"Paperini L"'

1. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.

Author

Viani S, Soldati E, DI Cori A, Segreti L, Paperini L, DE Lucia R, Zucchelli G, and Bongiorni MG

Subjects
Defibrillators, Electric Countershock instrumentation, Electric Countershock methods, Humans, Practice Guidelines as Topic, Primary Prevention methods, Secondary Prevention methods, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable, Wearable Electronic Devices
Abstract

The implantable cardioverter defibrillator (ICD) is today an indisputable evidence-based treatment for cardiac sudden death both in primary and secondary prevention. However many clinical conditions that would represent an indication to ICD implantation, according to guidelines, may be potentially reversible or may be accompanied by temporary contraindications to the implant. Moreover transvenous cardioverter defibrillator implantation still carries a not negligible risk of complications both acutely and at follow-up. The Wearable Cardioverter Defibrillator and the Subcutaneous Defibrillator are two recently developed technologies that can potentially overcome the aforementioned limitations of traditional transvenous ICDs. This review will discuss the main aspects of these 2 technologies, the data coming from clinical experiences and future perspectives.

Published
2018
Full Text
View/download PDF

2. Subcutaneous Implantable Defibrillator in an acromegalic pregnant woman for secondary prevention of sudden cardiac death: When (2) technologies save (2) lives.

Author

Viani S, Zucchelli G, Paperini L, Soldati E, Segreti L, Di Cori A, Menichetti F, Coluccia G, Andreini D, Branchitta G, and Bongiorni MG

Subjects
Acromegaly complications, Acromegaly diagnostic imaging, Adult, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Complications, Cardiovascular diagnostic imaging, Secondary Prevention trends, Acromegaly therapy, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable trends, Human Growth Hormone metabolism, Pregnancy Complications, Cardiovascular prevention & control, Secondary Prevention methods
Published
2016
Full Text
View/download PDF

3. Subcutaneous implantable cardiac defibrillators: indications and limitations.

Author

Bongiorni MG, Viani S, Zucchelli G, Di Cori A, Segreti L, Paperini L, Levorato D, Boem A, Branchitta G, Andreini D, and Soldati E

Subjects
Arrhythmias, Cardiac complications, Arrhythmias, Cardiac therapy, Clinical Trials as Topic, Death, Sudden, Cardiac etiology, Heart Failure complications, Heart Failure therapy, Humans, Prosthesis Design, Prosthesis Failure, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable adverse effects
Abstract

The implantable cardioverter defibrillator is today an indisputable evidence-based treatment for cardiac sudden death both in primary and secondary prevention. However, trans-venous cardioverter defibrillator implantation still carries a not negligible risk of complications both acutely and during follow-up. Trans-venous endocardial lead is the weak link of implantable cardioverter defibrillator (ICD) technology being the source of most mechanical complications on vessels and heart structures and exposed to infection, malfunction and recalls. A totally subcutaneous defibrillation lead has recently been introduced in clinical practice. With the subcutaneous pulse generator forms a defibrillation system that leaves the vessels and the heart completely "untouched." Subcutaneous ICD has proven to be safe and effective in many clinical trials. Patients without pacing indications and at higher risk of complications from trans-venous lead implantation represent the perfect candidates to S-ICD technology. However, with technical improvement, it is reasonable to expect a further expansion of indications.

Published
2015
Full Text
View/download PDF

4. [Sudden cardiac death: prevention when is right! From evidence-based medicine to family-based medicine].

Author

Paperini L, Genovesi A, and Carluccio M

Subjects
Angiotensin-Converting Enzyme Inhibitors therapeutic use, Antihypertensive Agents therapeutic use, Carbazoles therapeutic use, Carvedilol, Europe, Family Practice, Humans, Propanolamines therapeutic use, Randomized Controlled Trials as Topic, Risk Factors, Stroke Volume, United States, Vasodilator Agents therapeutic use, Ventricular Dysfunction, Left drug therapy, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable statistics & numerical data, Evidence-Based Medicine
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results